Abstract
Genetic engineering offers many advantages for the 1) production of immunotoxins (ITs) and 2) design of more effective reagents. In Chapter 9, J.R. Murphy discusses the use of genetic engineering to link genes together resulting in chimeric proteins. This review covers the first applications of genetic engineering technology to improve ITs by studying and altering toxin B chains and broadening the therapeutic index between target and nontarget cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Olsnes, S., Sandvig, K., Refnes, K., and Pihl, A. (1976) Rates of different steps involved in the inhibition of protein synthesis by the toxic lectins abrin and ricin. J. Biol. Chem., 251, 3985–3992.
Youle, R.J., and Huang, A.H.C. (1976) Protein bodies from the endosperm of castor bean: subfractionation, protein components, lectins, and changes during germination. Plant Physiol., 58, 703–709.
Tully, R.E., and Beevers, H. (1976) Protein bodies of castor bean endosperm isolation fractionation and the characterization of protein components. Plant Physiol., 58, 710–716.
Hailing, K.C., Hailing, A.C., Murray, E.E., Ladin, B.F., Houston, L.L., and Weaver, R.F. (1985) Genomic cloning and characterization of a ricin gene from Ricinus communis. Nucl. Acids Res., 13, 8019–8033.
Lamb, F.I., Roberts, L.M., and Lord, J.M. (1985) Nucleotide sequence of cloned cDNA coding for preproricin. Eur. J. Biochem., 148, 265–270.
Yoshitake, S., Funatsu, G., and Funatsu, M. (1978) Isolation and sequences of peptic peptides and the complete sequence of isoleucine chain of ricin D. Agic. Biol. Chem., 42, 1267–1274.
Funatsu, G., Kimura, M., and Funatsu, M. (1979) Primary structure of alanine chain of ricin D. Agric. Biol. Chem., 42, 2221–2224.
Lord, J.M. (1985) Precursors of ricin and Ricinus communis agglutinin. Glycosylation and processing during synthesis and intracellular transport. Eur. J. Biochem., 146, 411–416.
Nanno, S., Ishiguro, M., Funatsa, G., and Funatsu, M. (1975) The mode of binding of carbohydrate in ricin D. Agric. Biol. Chem., 39, 1651–1654.
Thorpe, P.E., Detre, S.I., Foxwell, B.M., Brown, A.N. F., Skilleter, D.N., Wilson, G., Forrester, J.A., and Stirpe, F. (1985) Modification of the carbohydrate in ricin with metaperiodate-cyanoborohydride mixtures. Effects on toxicity and in vivo distribution. Eur. J. Biochem., 147, 197–206.
Araki, T., and Funatsu, G. (1987) The complete amino acid sequence of the B-chain of ricin E isolated from small-grain castor bean seeds. Ricin E is a gene recombination product of ricin D and Ricinus communis agglutinin. Biochim. Biophys. Acta, 911, 191–200.
Colombatti, M., Johnson, V.G., Skopicki, H.A., Fendley, B., Lewis, M.S, and Youle, R.J. (1987) J. Immunol., 138, 3339–3344.
Nicolson, G.L., and Blaustein, J. (1972) The interaction of Ricinus communis agglutinin with normal and tumor cell surfaces. Biochim. Biophys. Acta, 266, 543–547.
Roberts, L.M., Lamb, F.I., Pappin, D.J., and Lord, J.M. (1985) The primary sequence of Ricinus communis agglutinin. Comparison with ricin. J. Biol. Chem., 260, 15682–15686.
Piatak, M. et al. (1986) Patent Cooperation Treaty, W085–03508.
Robertus, J.D., Piatak, M., Ferris, R., and Houston, L.L. (1987) Crystallization of ricin A chain obtained from a cloned gene expressed in Escherichia coll. J. Biol. Chem., 262, 19–20.
FitzGerald, D.J., Bjorn, M.J., Ferris, R.J., Winkelhake, J.L., Frankel, A.E., Hamilton, T.C., Ozols, R.F., Willingham, M.C., and Pastan, I. (1987) Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancer. Cancer Res., 47, 1407–1410.
Gregg, R.O., Bridges, S.A., Youle, R.J., Longo, D.L., Houston, L.L., Glennie, M.J., Stevenson, F.D., and Green, I. (1987) Whole ricin and recombinant ricin A chain idiotypespecific immunotoxins for therapy of the guinea pig L2C B cell leukemia. J. Immunol., 138, 4502–4508.
Youle, R.J., and Neville, D.M., Jr. (1982) Kinetics of protein synthesis inactivation by ricin-anti-Thy 1.1 monoclonal antibody hybrids. Role of the ricin B subunit demonstrated by reconstitution. J. Biol. Chem., 257, 1598–1601.
McIntosh, D.P., Edwards, D.C., Cumber, A.J., Parnell, G.D., Dean, C.J., Ross, W.C., and Forrester, J.A. (1983) Ricin B chain converts a non-cytotoxic antibody-ricin A chain conjugate into a potent and specific cytotoxic agent. FEBS Lett., 164, 17–20.
Vitetta, E.S., Fulton, R.J., and Uhr, J.W. (1984) Cytotoxicity of a cell-reactive immunotoxin containing ricin A chain is potentiated by an anti-immunotoxin containing ricin B chain. J. Exp. Med., 160, 341–346.
Youle, R.J., and Colombatti, M. In: Monoclonal Antibodies and Cancer, J. Roth, ed. Futura Publishing Company, pp 173–213.
Youle, R.J., Murray, G.J., and Neville, D.M., Jr. (1981) Studies on the galactose-binding site of ricin and the hybrid toxin Man6P-ricin. Cell, 23, 551–559.
Vitetta, E.S. (1986) Synergy between immunotoxins prepared with native ricin A chains and chemically-modified ricin B chains. J. Immunol., 136, 1880–1887.
Goldmacher, V.S., Anderson, J., Schulz, M.L., Blattler, W. A., and Lambert, J.M. (1987) Somatic cell mutants resistant to ricin, diphtheria toxin, and to immunotoxins. J. Biol. Chem., 262, 3205–3209.
Youle, R.J., and Colombatti, M. (1987) Hybridoma cells containing intracellular anti-ricin antibodies show ricin meets secretory antibody before entering the cytosol. J. Biol. Chem., 262, 4676–4682.
Neufeld, E. and Ashwell, G. In: Biochemistry of Glycoproteins and Proteoglycans. W. Lennarz, ed. Plenum Press, New York, pp 241.
Hubbard, A.L., Wilson, G., Ashwell, G., and Stukenbrok, H. (1979) An electron microscope autoradiographic study of the carbohydrate recognition systems in rat liver. I. Distribution of 125I-ligands among the liver cell types. J. Cell. Biol., 83, 47.
Stahl, P.D., Rodman, J.S., Miller, M.J., and Schlesinger, P.H. (1978) Evidence for receptor-mediated binding of glyco-proteins, glycoconjugates, and lysosomal glycosidases by alveolar macrophages. Proc. Natl. Acad. Sci. USA, 75, 1399–1403.
Colombatti, M., Greenfield, L., and Youle, R.J. (1986) Cloned fragment of diphtheria toxin linked to T cell-specific antibody identifies regions of B chain active in cell entry. J. Biol. Chem., 261, 3030–3035.
Greenfield, L., Johnson, V.G., and Youle, R.J. (1987) Science, 238, 536–539.
Eisenberg, D., Schwartz, E., Komaromy, M., and Wall, R. (1984) Analysis of membrane and surface protein sequences with the hydrophobic moment plot. J. Mol. Biol., 179, 125–142.
Boquet, P., Silverman, M.S., Pappenheimer, A.M., Jr., and Vernon, W. (1976) Binding of triton X-100 to diphtheria toxin, crossreacting material 45, and their fragments. Proc. Natl. Acad. Sci. USA, 73, 4449–4453.
Sandvig, K., and Olsnes, S. (1986) Rapid entry of nicked diphtheria toxin into cells at low pH. Characterization of the entry process and effects of low pH on the toxin molecule. J. Biol. Chem., 256, 9068–9076.
Donovan, J.J., Simon, M.T., Draper, R.K., and Montal, M. (1981) Diphtheria toxin forms transmembrane channels in planar lipid bilayers. Proc. Natl. Acad. Sci. USA, 78, 172–176.
Kim, K., and Groman, N.B. (1965) Mode of inhibition of diphtheria toxin by ammonium chloride. J. Bacteriol., 90, 1557–1562.
Draper, R.K., and Simon, M.I. (1980) The entry of diphtheria toxin into the mammalian cell cytoplasm: Evidence for lysosomal involvement. J. Cell. Biol., 87, 849–854.
Sandvig, K., and Olsnes, S. (1980) Diphtheria toxin entry into cells is facilitated by low pH. J. Cell. Biol., 87, 828–832.
Olsnes, S., and Sandvig, K. (1986) Interactions between diphtheria toxin entry and anion transport in Vero cells. II. Inhibition of anion antiport by diphtheria toxin. J. Biol. Chem., 261, 1553–1561.
Middlebrook, J.L., and Dorland, R.B. (1979) Protection of mammalian cells from diphtheria toxin by exogenous nucleotides. Can. J. Microbiol., 25, 285–290.
Proia, R.L., Wray, S.K., Hart, D.A., and Eidels, L. (1980) Characterization and affinity labeling of the cationic phosphate-binding (nucleotide-binding) peptide located in the receptor-binding region of the B-fragment of diphtheria toxin. J. Biol Chem., 255, 12025–12033.
Oda, T., Aizona, Y., and Funatsu, G. (1976) Binding and cytotoxicity of Ricinus communis lectins to HeLa cells, Sarcoma 180 ascites tumor cells and erythrocytes. J. Biochem., 96, 377.
Montesamo, L., Cawley, D., and Hershman, H.R. (1982) Disuccini-midyl suberate cross-linked ricin does not inhibit cell-free protein synthesis. Biochem. Biophys, Res. Comm., 109, 7–13.
Mashuo, Y., Kishida, K., Saito, M., Umemoto, N., and Hara, T. (1982) Importance of the antigen-binding valency and the nature of the cross-linking bond in ricin A-chain conjugates with antibody. J. Biochem., 91, 1583–1591.
Letvin, N.L., Goldmacher, V.S., Ritz, J., Yetz, J.M., Schlossman, S.F., and Lambert, J.M. (1986) In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. In vivo stability of disulfide-linked immunotoxin conjugates. J. Clin. Invest., 77, 977–984.
Youle, R.J., and Neville, D.M., Jr. (1980) Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin. Proc. Natl. Acad. Sci. USA, 77, 5483–5486.
Stong, R.C., Youle, R.J., and Vallera, D.A. (1984) Elimination of clonogenic T-leukemic cells from human bone marrow using anti-M, 65,000 protein immunotoxins. Cancer Res., 44, 3000–3006.
Lewis, M.W., and Youle, R.J. (1986) Ricin subunit association. Thermodynamics and the role of the disulfide bond in toxicity. J. Biol. Chem., 261, 11571–11577.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Kluwer Academic Publishers
About this chapter
Cite this chapter
Youle, R.J., Greenfield, L., Johnson, V.G. (1988). Genetic engineering of immunotoxins. In: Frankel, A.E. (eds) Immunotoxins. Cancer Treatment and Research, vol 37. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1083-9_8
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1083-9_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8419-2
Online ISBN: 978-1-4613-1083-9
eBook Packages: Springer Book Archive